Evolutionary analysis of HBV "S" antigen genetic diversity in Iranian blood donors: A nationwide study

Journal of Medical Virology

Volumn 86, Issue 1, 2014, Pages 144-155

  Pourkarim, Mahmoud Reza ^a,b   Sharifi, Zohre ^b   Soleimani, Ali ^b   Amini Bavil Olyaee, Samad ^c   Elsadek Fakhr, Ahmed ^a   Sijmons, Steven ^a   Vercauteren, Jurgen ^a   Karimi, Gharib ^b   Lemey, Philippe ^a   Maes, Piet ^a   Alavian, Seyed Moayed ^c,d   Van Ranst, Marc ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Middle East Liver Diseases Center (MELD Centers)   (Iran)

Author keywords

Blood donors; Evolution; HBsAg; Hepatitis B virus; Iran; Mutation

Indexed keywords

HEPATITIS B SURFACE ANTIGEN;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD DONOR; CROSS-SECTIONAL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NUCLEOTIDE SEQUENCE; PHYLOGENY; SEQUENCE ANALYSIS; STOP CODON; VIRUS CARRIER; VIRUS GENE;

HEPATITIS B VIRUS;

BLOOD DONORS; EVOLUTION; HBSAG; HEPATITIS B VIRUS; IRAN; MUTATION;

ADOLESCENT; ADULT; BLOOD DONORS; CARRIER STATE; CLUSTER ANALYSIS; CROSS-SECTIONAL STUDIES; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EVOLUTION, MOLECULAR; FEMALE; GENETIC VARIATION; GENOTYPE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IRAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION RATE; MUTATION, MISSENSE; PHYLOGENY; POINT MUTATION; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84887823968     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23798     Document Type: Article

References (74)

1. Abdo AA, Al-Jarallah BM, Sanai FM, Hersi AS, Al-Swat K, Azzam NA, Al-Dukhayil M, Al-Maarik A, Al-Faleh FZ. 2006. Hepatitis B genotypes: Relation to clinical outcome in patients with chronic hepatitis B in Saudi Arabia. World J Gastroenterol 12:7019-7024.
2. Aiyar A. 2000. The use of CLUSTAL W and CLUSTAL X for multiple sequence alignment. Methods Mol Biol 132:221-241.
3. Alavian SM. 2012. Occult hepatitis B virus infection among hemodialysis patients. Hepat Mon 12:242-243.
4. Allain JP, Candotti D. 2012. Hepatitis B virus in transfusion medicine: Still a problem? Biologicals 40:180-186.
5. Amini-Bavil-Olyaee S, Alavian SM, Adeli A, Sarrami-Forooshani R, Sabahi F, Sabouri E, Tavangar HR, Azizi M, Mahboudi F. 2006. Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: A preliminary report. J Med Virol 78:358-364.
6. Amini-Bavil-Olyaee S, Maes P, Van Ranst M, Pourkarim MR. 2012. Providing strong evidence of nosocomial outbreak of hepatitis B virus infection. J Hosp Infect 80:269-270 ; author reply 270-262.
7. Avellon A, Echevarria JM. 2006. Frequency of hepatitis B virus 'a' determinant variants in unselected Spanish chronic carriers. J Med Virol 78:24-36.
8. Banerjee A, Chandra PK, Datta S, Biswas A, Bhattacharya P, Chakraborty S, Chakrabarti S, Bhattacharya SK, Chakravarty R. 2007. Frequency and significance of hepatitis B virus surface gene variant circulating among 'antiHBc only' individuals in Eastern India. J Clin Virol 40:312-317.
9. Bozdayi G, Turkyilmaz AR, Idilman R, Karatayli E, Rota S, Yurdaydin C, Bozdayi AM. 2005. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol 76:476-481.
10. Carman WF. 1997. The clinical significance of surface antigen variants of hepatitis B virus. J Viral Hepat 4:11-20.
11. Cento V, Mirabelli C, Dimonte S, Salpini R, Han Y, Trimoulet P, Bertoli A, Micheli V, Gubertini G, Cappiello G, Spano A, Longo R, Bernassola M, Mazzotta F, De Sanctis GM, Zhang XX, Verheyen J, D'Arminio Monforte A, Ceccherini-Silberstein F, Perno CF, Svicher V. 2012. Overlapping structure of HBV genome and immune selection pressure are critical forces modulating HBV evolution. J Gen Virol 94:143-149.
12. Chandra PK, Biswas A, Datta S, Banerjee A, Panigrahi R, Chakrabarti S, De BK, Chakravarty R. 2009. Subgenotypes of hepatitis B virus genotype D (D1, D2, D3 and D5) in India: Differential pattern of mutations, liver injury and occult HBV infection. J Viral Hepat 16:749-756.
13. Chang MH. 2010. Breakthrough HBV infection in vaccinated children in Taiwan: Surveillance for HBV mutants. Antivir Ther 15:463-469.
14. Coleman PF. 2006. Surveillance for hepatitis B surface antigen mutants. J Med Virol 78:S56-S58.
15. Coleman PF, Chen YC, Mushahwar IK. 1999. Immunoassay detection of hepatitis B surface antigen mutants. J Med Virol 59:19-24.
16. Cooreman MP, Leroux-Roels G, Paulij WP. 2001. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8:237-247.
17. Crandall KA, Kelsey CR, Imamichi H, Lane HC, Salzman NP. 1999. Parallel evolution of drug resistance in HIV: Failure of nonsynonymous/synonymous substitution rate ratio to detect selection. Mol Biol Evol 16:372-382.
18. Datta S, Banerjee A, Chandra PK, Chakraborty S, Basu SK, Chakravarty R. 2007. Detection of a premature stop codon in the surface gene of hepatitis B virus from an HBsAg and antiHBc negative blood donor. J Clin Virol 40:255-258.
19. Doosti A, Amini-Bavil-Olyaee S, Tajbakhsh E, Adeli A, Mahboudi F. 2009. Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran. New Microbiol 32:193-198.
20. Echevarria JM, Avellon A. 2006. Hepatitis B virus genetic diversity. J Med Virol 78:S36-S42.
21. Echevarria JM, Avellon A. 2008. Improved detection of natural hepatitis B virus surface antigen (HBsAg) mutants by a new version of the VITROS HBsAg assay. J Med Virol 80:598-602.
22. Echevarria JM, Avellon A, Magnius LO. 2005. Molecular epidemiology of hepatitis B virus in Spain: Identification of viral genotypes and prediction of antigenic subtypes by limited sequencing. J Med Virol 76:176-184.
23. Garmiri P, Rezvan H, Abolghasemi H, Allain JP. 2011. Full genome characterization of hepatitis B virus strains from blood donors in Iran. J Med Virol 83:948-952.
24. Gerlich WH. 2006. Breakthrough of hepatitis B virus escape mutants after vaccination and virus reactivation. J Clin Virol 36:S18-S22.
25. Ho M, Mau Y, Lu C, Huang S, Hsu L, Lin S, Hsu H. 1998. Patterns of circulating hepatitis B surface antigen variants among vaccinated children born to hepatitis B surface antigen carrier and non-carrier mothers. A population-based comparative study. J Biomed Sci 5:355-362.
26. Hollinger FB. 2007. Hepatitis B virus genetic diversity and its impact on diagnostic assays. J Viral Hepat 14:11-15.
27. Hou J, Wang Z, Cheng J, Lin Y, Lau GK, Sun J, Zhou F, Waters J, Karayiannis P, Luo K. 2001. Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34:1027-1034.
28. Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, Trepo C, Kay A. 2004. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 73:508-515.
29. Katsoulidou A, Paraskevis D, Magiorkinis E, Moschidis Z, Haida C, Hatzitheodorou E, Varaklioti A, Karafoulidou A, Hatzitaki M, Kavallierou L, Mouzaki A, Andrioti E, Veneti C, Kaperoni A, Zervou E, Politis C, Hatzakis A. 2009. Molecular characterization of occult hepatitis B cases in Greek blood donors. J Med Virol 81:815-825.
30. Kay A, Zoulim F. 2007. Hepatitis B virus genetic variability and evolution. Virus Res 127:164-176.
31. Kfoury Baz EM, Zheng J, Mazuruk K, Van Le A, Peterson DL. 2001. Characterization of a novel hepatitis B virus mutant: demonstration of mutation-induced hepatitis B virus surface antigen group specific "a" determinant conformation change and its application in diagnostic assays. Transfus Med 11:355-362.
32. Kim SW, Kim DU, Kim JK, Kang LW, Cho HS. 2008. Crystal structure of Pfu, the high fidelity DNA polymerase from Pyrococcus furiosus. Int J Biol Macromol 42:356-361.
33. Kitab B, El Feydi AE, Afifi R, Derdabi O, Cherradi Y, Benazzouz M, Rebbani K, Brahim I, Salih Alj H, Zoulim F, Trepo C, Chemin I, Ezzikouri S, Benjelloun S. 2011. Hepatitis B genotypes/subgenotypes and MHR variants among Moroccan chronic carriers. J Infect 63:66-75.
34. Kramvis A, Arakawa K, Yu MC, Nogueira R, Stram DO, Kew MC. 2008. Relationship of serological subtype, basic core promoter and precore mutations to genotypes/subgenotypes of hepatitis B virus. J Med Virol 80:27-46.
35. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. 2007. Distribution of HBV genotypes, subgenotypes and HBsAg subtypes among chronically infected patients in Serbia. Arch Virol 152:2017-2025.
36. Lazarevic I, Cupic M, Delic D, Svirtlih NS, Simonovic J, Jovanovic T. 2010. Prevalence of hepatitis B virus MHR mutations and their correlation with genotypes and antiviral therapy in chronically infected patients in Serbia. J Med Virol 82:1160-1167.
37. Lusida MI, Nugrahaputra VE, Soetjipto Handajani R, Nagano-Fujii M, Sasayama M, Utsumi T, Hotta H. 2008. Novel subgenotypes of hepatitis B virus genotypes C and D in Papua, Indonesia. J Clin Microbiol 46:2160-2166.
38. Ly TD, Servant-Delmas A, Bagot S, Gonzalo S, Ferey MP, Ebel A, Dussaix E, Laperche S, Roque-Afonso AM. 2006. Sensitivities of four new commercial hepatitis B virus surface antigen (HBsAg) assays in detection of HBsAg mutant forms. J Clin Microbiol 44:2321-2326.
39. Ma Q, Wang Y. 2012. Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol 84:198-206.
40. Mahabadi M, Norouzi M, Alavian SM, Samimirad K, Azad TM, Saberfar E, Mahmoodi M, Ramezani F, Karimzadeh H, Malekzadeh R, Montazeri G, Nejatizadeh A, Ziaee M, Abedi F, Ataei B, Yaran M, Sayad B, Hossein Somi M, Sarizadeh G, Sanei-Moghaddam I, Mansour-Ghanaei F, Rafatpanah H, Pourhosseingholi MA, Keyvani H, Kalantari E, Saberifiroozi M, Ali Judaki M, Ghamari S, Daram M, Fazeli Z, Goodarzi Z, Khedive A, Moradi A, Jazayeri SM. 2013. Drug-related mutational patterns in hepatitis B virus (HBV) reverse transcriptase proteins from Iranian treatment-naive chronic HBV patients. Hepat Mon 13:e6712.
41. McMahon BJ. 2009. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int 3:334-342.
42. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, Rostami Nejad M, Antikchi MH, Sabahi F, Zali MR. 2008. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect 14:858-866.
43. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Damavand B, Azimzadeh P, Derakhshan F, Sabahi F, Zali MR. 2012. Characterization of hepatitis B virus genome variability in Iranian patients with chronic infection, a nationwide study. J Med Virol 84:414-423.
44. Mumtaz K, Hamid S, Ahmed S, Moatter T, Mushtaq S, Khan A, Mizokami M, Jafri W. 2011. A study of genotypes, mutants and nucleotide sequence of hepatitis B virus in Pakistan: HBV genotypes in Pakistan. Hepat Mon 11:14-18.
45. Norder H, Courouce AM, Coursaget P, Echevarria JM, Lee SD, Mushahwar IK, Robertson BH, Locarnini S, Magnius LO. 2004. Genetic diversity of hepatitis B virus strains derived worldwide: Genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47:289-309.
46. Ozaslan M, Ozaslan E, Barsgan A, Koruk M. 2007. Mutations in the S gene region of hepatitis B virus genotype D in Turkish patients. J Genet 86:195-201.
47. Pourkarim MR, Van Ranst M. 2011. Guidelines for the detection of a common source of hepatitis B virus infections. Hepat Mon 11:783-785.
48. Pourkarim MR, Verbeeck J, Rahman M, Amini-Bavil-Olyaee S, Forier AM, Lemey P, Maes P, Van Ranst M. 2009. Phylogenetic analysis of hepatitis B virus full-length genomes reveals evidence for a large nosocomial outbreak in Belgium. J Clin Virol 46:61-68.
49. Pourkarim MR, Amini-Bavil-Olyaee S, Lemey P, Maes P, Van Ranst M. 2010a. Are hepatitis B virus "subgenotypes" defined accurately? J Clin Virol 47:356-360.
50. Pourkarim MR, Amini-Bavil-Olyaee S, Verbeeck J, Lemey P, Zeller M, Rahman M, Maes P, Nevens F, Van Ranst M. 2010b. Molecular evolutionary analysis and mutational pattern of full-length genomes of hepatitis B virus isolated from Belgian patients with different clinical manifestations. J Med Virol 82:379-389.
51. Pourkarim MR, Lemey P, Amini-Bavil-Olyaee S, Houspie L, Verbeeck J, Rahman M, Maes P, Vanwijngaerden E, Nevens F, Van Ranst M. 2011. Molecular characterization of hepatitis B virus strains circulating in Belgian patients co-infected with HIV and HBV: Overt and occult infection. J Med Virol 83:1876-1884.
52. Pournik O, Alavian SM, Ghalichi L, Hajibeigi B, Razavi AR, Eslami S. 2013. Lower intrafamilial transmission rate of hepatitis B in patients with hepatitis d coinfection: A data-mining approach. Hepat Mon 13:e7652.
53. Purdy MA, Talekar G, Swenson P, Araujo A, Fields H. 2007. A new algorithm for deduction of hepatitis B surface antigen subtype determinants from the amino acid sequence. Intervirology 50:45-51.
54. Sayiner AA, Ozcan A, Sengonul A. 2008. Naturally occurring MHR variants in Turkish patients infected with hepatitis B virus. J Med Virol 80:405-410.
55. Scheiblauer H, Soboll H, Nick S. 2006. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol 78:S66-S70.
56. Seddigh-Tonekaboni S, Lim WL, Young B, Hou JL, Waters J, Luo KX, Thomas HC, Karayiannis P. 2001. Hepatitis B surface antigen variants in vaccinees, blood donors and an interferon-treated patient. J Viral Hepat 8:154-158.
57. Smolle E, Zohrer E, Bettermann K, Haybaeck J. 2012. Viral hepatitis induces hepatocellular cancer: What can we learn from epidemiology comparing Iran and worldwide findings? Hepat Mon 12:e7879.
58. Song BC, Kim H, Kim SH, Cha CY, Kook YH, Kim BJ. 2005a. Comparison of full length sequences of hepatitis B virus isolates in hepatocellular carcinoma patients and asymptomatic carriers of Korea. J Med Virol 75:13-19.
59. Song BC, Kim SH, Kim H, Ying YH, Kim HJ, Kim YJ, Yoon JH, Lee HS, Cha CY, Kook YH, Kim BJ. 2005b. Prevalence of naturally occurring surface antigen variants of hepatitis B virus in Korean patients infected chronically. J Med Virol 76:194-202.
60. Stramer SL, Wend U, Candotti D, Foster GA, Hollinger FB, Dodd RY, Allain JP, Gerlich W. 2011. Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 364:236-247.
61. Tajbakhsh E, Abbasian B, Esmaeili A, Behjati M. 2011. Seroprevalence of anti-HDV Ab and socioepidemiological characteristics among HBsAg-positive blood donors in Charmahal-o-Bakhtiyari province, Iran: Anti-HDV among HBsAg-positive blood donors. Hepat Mon 11:130-131.
62. Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S. 2011. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evo 28:2731-2739.
63. Vaezjalali M, Rashidpour S, Rezaee H, Hajibeigi B, Zeidi M, Gachkar L, Aghamohamad S, Najafi R, Goudarzi H. 2013. Hepatitis B viral DNA among HBs antigen negative healthy blood donors. Hepat Mon 13:e6590.
64. van de Klundert MA, Cremer J, Kootstra NA, Boot HJ, Zaaijer HL. 2012. Comparison of the hepatitis B virus core, surface and polymerase gene substitution rates in chronically infected patients. J Viral Hepat 19:e34-e40.
65. Veazjalali M, Norder H, Magnius L, Jazayeri SM, Alavian SM, Mokhtari-Azad T. 2009. A new core promoter mutation and premature stop codon in the S gene in HBV strains from Iranian patients with cirrhosis. J Viral Hepat 16:259-264.
66. Warner N, Locarnini S. 2008. The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48:88-98.
67. Weber B. 2005. Genetic variability of the S gene of hepatitis B virus: Clinical and diagnostic impact. J Clin Virol 32:102-112.
68. Weber B. 2006. Diagnostic impact of the genetic variability of the hepatitis B virus surface antigen gene. J Med Virol 78:S59-S65.
69. Yeh CT. 2010. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide/nucleoside analogue therapy. Antivir Ther 15:471-475.
70. Yong-Lin Y, Qiang F, Ming-Shun Z, Jie C, Gui-Ming M, Zu-Hu H, Xu-Bing C. 2012. Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virol J 9:82.
71. Yousif M, Kramvis A. 2013. Genotype D of hepatitis B virus and its subgenotypes: An update. Hepatol Res 43:355-364.
72. Zehender G, Ebranati E, Gabanelli E, Shkjezi R, Lai A, Sorrentino C, Lo Presti A, Basho M, Bruno R, Tanzi E, Bino S, Ciccozzi M, Galli M. 2012. Spatial and temporal dynamics of hepatitis B virus D genotype in Europe and the Mediterranean Basin. PLoS ONE 7:e37198.
73. Zidan A, Scheuerlein H, Schule S, Settmacher U, Rauchfuss F. 2012. Epidemiological pattern of hepatitis B and hepatitis C as etiological agents for hepatocellular carcinoma in Iran and worldwide. Hepat Mon 12:e6894.
74. Zuckerman AJ, Zuckerman JN. 1999. Molecular epidemiology of hepatitis B virus mutants. J Med Virol 58:193-195.